Klin Monbl Augenheilkd 2000; 216(6): 424-427
DOI: 10.1055/s-2000-10590
DIAGNOSTISCHES FORUM

Georg Thieme Verlag Stuttgart · New York

Diffuse retinale Pigmentepitheliopathie unter systemischer Therapie mit Kortikosteroiden[1] [2]

Retinal pigment epithelial changes associated with systemic corticosteroid treatmentChristoph  W. Spraul, Martha  J. Jakobczyk-Zmija, Gerhard  K. Lang, Gabriele  E. Lang
  • Universitäts-Augenklinik Ulm, Prittwitzstraße 43, 89075 Ulm (Direktor: Prof. Dr. G. K. Lang),
  • E-mail: christoph.spraul@medizin.uni-ulm.de
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Zusammenfassung

Hintergrund Sowohl nach lokaler als auch nach systemischer Kortikosteroidbehandlung kann es zu okulären Nebenwirkungen kommen. Neben den häufigen Nebenwirkungen wie Entwicklung einer Katarakt und Erhöhung des intraokularen Druckes, kann es in seltenen Fällen zu einer diffusen retinalen Pigmentepitheliopathie kommen.

Patient Ein 64-jähriger Patient stellte sich mit erheblicher Visusminderung an beiden Augen vor. Diese hatte sich innerhalb von 6 Wochen langsam entwickelt. Die ophthalmologische Untersuchung zeigte beiderseits eine massive diffuse retinale Pigmentepitheliopathie mit seröser Abhebung der neurosensorischen Netzhaut. Der Patient wurde wegen einer chronischen Glomerulonephritis seit längerer Zeit mit Methylprednisolon behandelt. Nach Absetzten dieser systemischen Steroidtherapie kam es zum deutlichen Visusanstieg und zur Rückbildung der serösen Abhebung der neurosensorischen Netzhaut.

Schlußfolgerung Patienten, die über längere Zeit mit Steroiden behandelt werden, sollten deshalb regelmäßig ophthalmologisch untersucht werden. Bei Vorliegen einer Pigmentepitheliopathie sollte, wenn möglich, die Steroidtherapie reduziert bzw. vollständig abgesetzt werden.

Background It is well known that topical as well as systemic treatment with corticosteroids may have ocular side effects. The most common are the development of cataract and increase of intraocular pressure, however, alteration of the retinal pigment epithelium may also occur.

Patient A 64-year old male experienced a progressive decrease of visual acuity over a time period of 6 weeks. Ophthalmologic examination revealed a severe diffuse retinal pigment epitheliopathy with serous detachment of the neurosensory retina. This patient was treated with systemic methylprednisolone for chronic glomerulonephritis. After cessation of the treatment with systemic corticosteroids visual acuity improved and the serous retinal detachment resolved.

Conclusion Ophthalmologic examination including biomicroscopy of the retina is recommended on a regular basis for patients treated with systemic corticosteroids. With development of pigment epithelial changes steroids should be reduced or discontinued if possible.

1 Manuskript eingereicht am 9. 2. 00 und in der vorliegenden Form angenommen.

2 Herrn Prof. Dr. G. O. H. Naumann gewidmet.

Literatur

1 Manuskript eingereicht am 9. 2. 00 und in der vorliegenden Form angenommen.

2 Herrn Prof. Dr. G. O. H. Naumann gewidmet.

  • 01 Abe  H, Sonoda  H, Sato  I. Central serous choroidopathy presumably aggravated by steroids.  Jpn Rev Clin Ophthalmol. 1983;  77 660
  • 02 Akagi  Y, Ogawa  K, Hara  I, et al. A case of multiple posterior pigment epitheliopathy after renal transplantation from a cadaver.  Nippon Ganka Kiyou. 1990;  41 1216-1220
  • 03 Alm  A. The effect of sympathetic stimulation on blood flow through the uvea, retina, and optic nerve in monkeys (Macaca irus).  Exp Eye Res. 1977;  25 19-24
  • 04 Bouzas  E A, Scott  M H, Mastorakos  G, et al. Central serous chorioretinopathy in endogenous hypercortisolism.  Arch Ophthalmol. 1993;  111 1229-1233
  • 05 Friberg  T R, Eller  A W. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation.  Graefes Arch Clin Exp Ophthalmol. 1990;  228 305-309
  • 06 Gass  J DM, Little  H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.  Ophthalmology. 1995;  102 737-747
  • 07 Giles  C L, Mason  G L, Duff  I F, McLean  J A. The association of cataract formation and systemic corticosteroid therapy.  JAMA. 1962;  182 719-722
  • 08 Harada  T, Harada  K. Six cases of central serous choroidopathy induced by systemic corticosteroids therapy.  Doc Ophthalmol. 1985;  60 37-44
  • 09 Hiwatashi  E, Miyahita  K. Multifocal posterior pigment epitheliopathy developed in a case of SLE retinopathy.  Ganka Rinsho Iho. 1993;  87 1030-1033
  • 10 Ikeda  N, Numata  K, Takedo  N, et al. A case of pigment epitheliopathy in a patient with polymyositis induced by corticosteroid therapy.  Nippon Ganka Kiyou. 1993;  44 1546-1551
  • 11 Inoue  T, Miyamoto  F. A case of central serous chorioretinopathy during corticosteroid treatment for Vogt-Koyanagi Harada syndrome.  Ganka Rinsho Iho. 1985;  79 1849-1853
  • 12 Jain  I S, Singh  K. Maculopathy a corticosteroid side-effect.  J All India Ophthalmol Soc. 1966;  14 250-252
  • 13 Kaneko  E, Nawano  M, Honda  N, et al. Ulcerative colitis complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment.  Dig Dis Sci V. 1985;  30 896-900
  • 14 Kato  Y, Kato  M, Kogure  M. Two cases of central serous choroidopathy in the course of steroid therapy.  Jpn Rev Clin Ophthalmol. 1982;  76 18-21
  • 15 Kinoshita  C, Yamashita  T, Yoshimura  T. A case of chronic nephritis with multifocal posterior pigment epitheliopathy.  Nippon Ganka Kiyo. 1988;  39 769-773
  • 16 Matsukura  S, Miyashita  K, Hiraga  S, et al. Four cases of central serous chorioretinopathy following renal transplantation.  Rinsho Ganka. 1993;  47 1719-1724
  • 17 Matsumoto  Y, Ishibashi  Y, Kono  K, et al. Bullous retinal detachment associated with malignant melanoma and massive steroid therapy.  Rinsho Ganka. 1983;  37 1377-1383
  • 18 Matsunaga  H, Nishimura  T, Uyama  N. Recent cases of multifocal posterior pigment epitheliopathy.  Rinsho Ganka. 1992;  46 729-733
  • 19 Melberg  N S, Olk  R J. Corticosteroid-induced ocular hypertension in the treatment of aphakic or pseudophakic cystoid macular edema.  Ophthalmology. 1993;  100 164-167
  • 20 Miura  K, Ueno  M, Miura  Y, et al. Central serous chorioretinopathy induced by systemic corticosteroid therapy.  Nippon Ganka Kiyo. 1989;  40 59-64
  • 21 Nolten  W E, Rueckert  P A. Elevated free cortisol index in pregnancy: possible regulatory mechanisms.  Am J Obstet Gynecol. 1981;  139 492-498
  • 22 Ogawa  T, Ishikawa  K, Inokuchi  T. A case of multifocal pigment epitheliopathy with nephrotic syndrome.  Nippon Ganka Kiyo. 1989;  40 1744-1751
  • 23 Polak  B CP, Baarsma  G S, Snyers  B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.  Br J Ophthalmol. 1995;  79 922-925
  • 24 Prünte  C, Flammer  J. Choroidal capillary and venous congestion in central serous chorioretinopathy.  Am J Ophthalmol. 1996;  121 26-34
  • 25 Prünte  C, Kain  H L. Enzymatic digestion increases permeability of the outer blood-retinal barrier for high-molecular-weight substances.  Graefes Arch Clin Exp Ophthalmol. 1995;  233 101-111
  • 26 Renfro  L, Snow  J S. Ocular effects of topical and systemic steroids.  Dermatol Clin. 1992;  10 505-512
  • 27 Schreiber  J B, Lakhanpal  V, Nasrallah  S M. Crohn's Disease complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment.  Dig Dis Sci. 1989;  34 118-122
  • 28 Shimaya  M, Yamazaki  Y, Imai  J. A case of therapy-resistant scleritis associated with chronic rheumatism.  Jpn Rev Clin Ophthalmol. 1978;  78 213-216
  • 29 Spraul  C W, Lang  G E, Lang  G K. Retinal Pigment Epithelial Changes Associated With Systemic Corticosteroid Treatment: Report of Cases and Review of the Literature.  Ophthalmologica. 1998;  212 142-148
  • 30 Spraul  C W, Lang  G E, Lang  G K. Zentrale seröse Chorioretinopathie unter systemischer Therapie mit Kortikosteroiden.  Ophthalmologe. 1997;  94 392-396
  • 31 Suehiro  T, Hosoya  T. A case of central serous chorioretinopathy during systemic corticosteroid therapy.  Nippon Ganka Kiyo. 1994;  45 879-882
  • 32 Suzuki  Y, Kogure  M, Kato  M, et al. A case of multifocal posterior pigment epitheliopathy following renal transplantation.  Ganka Rinsho Iho. 1986;  80 212-214
  • 33 Tamiya  R, Takahashi  K, Matsubara  T, et al. Multifocal posterior epitheliopathy in a case of lupus nephritis.  Rinsho Ganka. 1994;  48 1757-1763
  • 34 Wakakura  M, Ishikawa  S. Central serous chorioretinopathy complicating systemic corticosteroid treatment.  Br J Ophthalmol. 1984;  68 329-331
  • 35 Wakakura  M, Ishikawa  S. Central serous chorioretinopathy complicating systemic corticosteroid treatment.  Br J Ophthalmol. 1984;  68 329-331
  • 36 Wakakura  M, Yosida  H, Tani  I. Effect of systemic corticosteroid on the outer bloodretinal barrier: report of three cases.  Rinsho Ganka. 1981;  35 1037-1041
  • 37 Williamson  J, Nuki  G. Macular lesions during systemic therapy with depot tetracosactrin.  Br J Ophthalmol. 1970;  54 405-409
  • 38 Yamazaki  A, Tamai  A, Hamamoto  J, et al. A case of Fishers' syndrome associated with central serous chorioretinopathy.  Shinkei Ganka. 1995;  12 199-207
  • 39 Yannuzzi  L A, Shakin  J L, Fisher  Y L, Altomonte  M A. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy.  Ophthalmology. 1984;  91 1554-1572
  • 40 Yao  X-Y, Marmor  M F. Induction of serous retinal detachment in rabbit eyes by pigment epithelial and choriocapillary injury.  Arch Ophthalmol. 1992;  110 541-546
  • 41 Zweng  H C, Little  H L. Diffuse retinal pigment epitheliopathy. In: Argon laser photocoagulation.  CV Mosby Co., St Louis, Mo; 1977: 117-126
    >